60 related articles for article (PubMed ID: 17074677)
1. c-erb-B2 expression and response to treatment in metastatic breast cancer.
Bezwoda WR
Med Oncol; 2000 Feb; 17(1):22-8. PubMed ID: 10713656
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous metastases from breast carcinoma.
Ahmed M
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689852
[TBL] [Abstract][Full Text] [Related]
3. Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series.
Takuwa H; Tsuji W; Yotsumoto F
Int J Surg Case Rep; 2018; 52():125-131. PubMed ID: 30343261
[TBL] [Abstract][Full Text] [Related]
4. Long-responders to anti-HER2 therapies: A case report and review of the literature.
Cantini L; Pistelli M; Savini A; Bastianelli L; Della Mora A; Merloni F; Burattini M; Berardi R
Mol Clin Oncol; 2018 Jan; 8(1):147-152. PubMed ID: 29387408
[TBL] [Abstract][Full Text] [Related]
5. Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remission.
Haq R; Gulasingam P
Curr Oncol; 2016 Apr; 23(2):91-5. PubMed ID: 27122973
[TBL] [Abstract][Full Text] [Related]
6. Can maintenance trastuzumab be stopped in patients with HER2-positive metastatic breast cancer?
Hsieh A; Pittman K; Patterson WK; Townsend A
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26040825
[TBL] [Abstract][Full Text] [Related]
7. Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature.
Ihnenfeld Arciénega I; Imesch P; Fink D; Dedes KJ
Target Oncol; 2015 Jun; 10(2):297-301. PubMed ID: 25511015
[TBL] [Abstract][Full Text] [Related]
8. More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review.
Badulescu F; Badulescu A; Paul D; Popescu CF; Florescu C
Onco Targets Ther; 2014; 7():1911-7. PubMed ID: 25378932
[TBL] [Abstract][Full Text] [Related]
9. Sustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report.
Syrios J; Dokou A; Tsavaris N
J Med Case Rep; 2010 Dec; 4():401. PubMed ID: 21143954
[TBL] [Abstract][Full Text] [Related]
10. A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.
Shigematsu H; Nakamura Y; Tanaka K; Shiotani S; Koga C; Kawaguchi H; Nishimura S; Taguchi K; Nishiyama K; Ohno S
Int J Clin Oncol; 2010 Dec; 15(6):615-20. PubMed ID: 20473628
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
[TBL] [Abstract][Full Text] [Related]
12. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Petit T; Claude L; Carrie C
Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
14. A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Maciá Escalante S; Rodríguez Lescure A; Pons Sanz V; Martínez Banaclocha N; Guillén Ponce C; Carrato Mena A
Clin Transl Oncol; 2006 Oct; 8(10):761-3. PubMed ID: 17074677
[TBL] [Abstract][Full Text] [Related]
15. [Breast carcinoma in accessory gland: a case report].
Sivelli R; Del Rio P; Arcuri MF; Corcione L
G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
